Urological cancer, Malmö
1 – 100 of 499
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management : A PIONEER Analysis Based on Big Data
(
- Contribution to journal › Article
-
Mark
A pilot study of an organised population‐based testing programme for prostate cancer
(
- Contribution to journal › Article
-
Mark
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
(
- Contribution to journal › Article
-
Mark
Being a non-native English speaker in science and medicine
2024) In Nature Reviews Urology(
- Contribution to journal › Article
-
Mark
Deep learning performance on MRI prostate gland segmentation : evaluation of two commercially available algorithms compared with an expert radiologist
(
- Contribution to journal › Article
-
Mark
Shared decision-making before prostate cancer screening decisions
(
- Contribution to journal › Scientific review
-
Mark
Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial
2024) In European Urology(
- Contribution to journal › Article
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Апалутамид в комбинации с андрогендепривационной терапией в клинических подгруппах пациентов с метастатическим кастрационно-чувствительным раком предстательной железы : подгрупповой анализ рандомизированного клинического исследования TITAN
(
- Contribution to journal › Article
-
Mark
Violation of onco-surgical principles is associated with survival outcomes in upper tract urothelial carcinomas after radical nephroureterectomy
(
- Contribution to journal › Article
-
Mark
Investigating Ras homolog gene family member C (RhoC) and Ki67 expression following external beam radiation therapy show increased RhoC expression in relapsing prostate cancer xenografts
(
- Contribution to journal › Article
-
Mark
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer : A Register-based Nationwide Study
(
- Contribution to journal › Article
-
Mark
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography : Results of a Multicenter European Study
(
- Contribution to journal › Article
-
Mark
Evaluation of superficial xenograft volume estimation by ultrasound and caliper against MRI in a longitudinal pre-clinical radiotherapeutic setting
(
- Contribution to journal › Article
- 2023
-
Mark
The need for core outcome sets in renal cancer clinical effectiveness research
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
(
- Contribution to journal › Article
-
Mark
Salvage radiotherapy after radical prostatectomy : functional outcomes in the LAPPRO trial after 8-year follow-up
(
- Contribution to journal › Article
-
Mark
Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection
(
- Contribution to journal › Article
-
Mark
Pancreatic Cancer Organoids : An Emerging Platform for Precision Medicine?
(
- Contribution to journal › Scientific review
-
Mark
Men's Perception of Being Invited for Prostate Cancer Testing and the Information About Its Pros and Cons—A Survey from Two Population-based Testing Programmes
(
- Contribution to journal › Article
-
Mark
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer
(
- Contribution to journal › Article
-
Mark
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence : The PET index
(
- Contribution to journal › Article
-
Mark
Correlation between ADC, ADC ratio, and Gleason Grade group in prostate cancer patients undergoing radical prostatectomy : Retrospective multicenter study with different MRI scanners
(
- Contribution to journal › Article
-
Mark
Incidence and associated risk factors of venous thromboembolism after open and laparoscopic partial nephrectomy in patients administered short-period thromboprophylaxis : a Danish nationwide population-based cohort study
(
- Contribution to journal › Article
-
Mark
Urosymphyseal fistula after pelvic radiotherapy in a tertial referral centre - a rare entity with significant comorbidity requiring multidisciplinary management
(
- Contribution to journal › Article
-
Mark
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)
(
- Contribution to journal › Article
-
Mark
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Re : Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022 : The Urologist's Point of View
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer
(
- Contribution to journal › Scientific review
-
Mark
The role of phoenixin in the proliferation and migration of ectopic epithelial cells in vitro
(
- Contribution to journal › Article
-
Mark
Systematic Augmentation in HSV Space for Semantic Segmentation of Prostate Biopsies
2023) 22nd Scandinavian Conference on Image Analysis, SCIA 2023 In Lecture Notes in Computer Science 13886. p.293-308(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
P90 ribosomal S6 kinases : A bona fide target for novel targeted anticancer therapies?
(
- Contribution to journal › Scientific review
-
Mark
Deep learning algorithm performs similarly to radiologists in the assessment of prostate volume on MRI
(
- Contribution to journal › Article
-
Mark
Protein and amino acid intakes in relation to prostate cancer risk and mortality—A prospective study in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
Acoustophoresis enrichment of tumor cell clusters in blood of patients with metastatic prostate cancer
2023) The 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023)(
- Contribution to conference › Abstract
-
Mark
Pain as bad as you can imagine or extremely severe pain? A randomized controlled trial comparing two pain scale anchors
(
- Contribution to journal › Article
-
Mark
Acoustophoresis enriches tumor cell clusters in blood of patients with prostate cancer
2023) Acoustofluidics Conference 2023, St. Louis USA(
- Contribution to conference › Abstract
-
Mark
Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium
(
- Contribution to journal › Article
-
Mark
Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool
(
- Contribution to journal › Article
-
Mark
A Provider-Facing Decision Support Tool for Prostate Cancer Screening in Primary Care : A Pilot Study
(
- Contribution to journal › Article
-
Mark
Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations : The EAU-RF NIMBUS Trial
(
- Contribution to journal › Article
-
Mark
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer : A subgroup analysis of the randomised clinical TITAN study
(
- Contribution to journal › Article
-
Mark
suPARnostic : an advanced predictive tool for detecting recurrence in renal cell carcinoma
(
- Contribution to journal › Article
-
Mark
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups
(
- Contribution to journal › Article
-
Mark
Acoustic enrichment of heterogenous circulating tumor cells and clusters from patients with metastatic prostate cancer
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making : Proposal from the European Association of Urology Guidelines Panel
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma : Results from a Prospective Lymph Node Mapping Study
(
- Contribution to journal › Article
-
Mark
Transurethral versus open enucleation of the prostate in Sweden - a retrospective comparative cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Risk of hernia formation after radical prostatectomy : a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial
(
- Contribution to journal › Article
-
Mark
Analytical performance of aPROMISE : automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting
(
- Contribution to journal › Article
-
Mark
Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999 : a population-based study
(
- Contribution to journal › Article
-
Mark
Increasing rates of urinary- and bloodstream infections following transrectal prostate biopsy in South Sweden
(
- Contribution to journal › Article
-
Mark
Diagnostic and prognostic factors in patients with prostate cancer : a systematic review
(
- Contribution to journal › Scientific review
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2022 Update
(
- Contribution to journal › Scientific review
-
Mark
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
(
- Contribution to journal › Article
-
Mark
Reply to Wei Zhang So, Ziting Wang, and Ho Yee Tiong's Letter to the Editor re : Anna Lantz, David Bock, Olof Akre, et al. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up. Eur Urol 2021;80:650–60
(
- Contribution to journal › Letter
-
Mark
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?
(
- Contribution to journal › Letter
-
Mark
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
Establishing metastatic prostate cancer quality indicators using a modified Delphi approach
(
- Contribution to journal › Article
-
Mark
Complete metabolic response with [18F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer
(
- Contribution to journal › Article
-
Mark
Experimental in vivo model to evaluate the impact of Cernitin™ on pain response on induced chronic bladder inflammation
(
- Contribution to journal › Article
-
Mark
Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study
(
- Contribution to journal › Article
-
Mark
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
(
- Contribution to journal › Article
-
Mark
Robot-assisted nephroureterectomy for upper tract urothelial carcinoma—feasibility and complications : a single center experience
(
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article
-
Mark
Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme
(
- Contribution to journal › Article
-
Mark
Learning curve for robot-assisted laparoscopic radical prostatectomy in a large prospective multicentre study
(
- Contribution to journal › Article
-
Mark
Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer
(
- Contribution to journal › Article
-
Mark
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
(
- Contribution to journal › Article
-
Mark
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Noninvasive detection of any-stage cancer using free glycosaminoglycans
(
- Contribution to journal › Article
-
Mark
Detection of lymph node metastases in patients with prostate cancer : Comparing conventional and digital [18F]-fluorocholine PET-CT using histopathology as a reference
(
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
(
- Contribution to journal › Article
-
Mark
Nuclear expression of pSTAT3Tyr705 and pSTAT3Ser727 in the stromal compartment of localized hormone-naïve prostate cancer
(
- Contribution to journal › Article
-
Mark
Lymph swelling after radical prostatectomy and pelvic lymph node dissection
(
- Contribution to journal › Article
-
Mark
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Prostate Cancer Tissue Biomarkers
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer : Results from the Prospective, International, Observational Prostate Cancer Registry
(
- Contribution to journal › Article
-
Mark
Recurrence pattern in localized RCC : results from a European multicenter database (RECUR)
(
- Contribution to journal › Article
-
Mark
Community-onset urosepsis : incidence and risk factors for 30-day mortality–a retrospective cohort study
(
- Contribution to journal › Article
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
(
- Contribution to journal › Article
- 2021
-
Mark
Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11
(
- Contribution to journal › Article
-
Mark
Vesicourethral Anastomotic Stenosis After Open or Robot-assisted Laparoscopic Retropubic Prostatectomy—Results from the Laparoscopic Prostatectomy Robot Open Trial
(
- Contribution to journal › Article
-
Mark
Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial
(
- Contribution to journal › Article
-
Mark
IMAGINE—IMpact Assessment of Guidelines Implementation and Education : The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
An Artificial Intelligence-based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies
(
- Contribution to journal › Article
-
Mark
Contemporary use of phytotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia : results from the EVOLUTION European registry
(
- Contribution to journal › Article
-
Mark
Penile intraepithelial neoplasia, penile cancer precursors and human papillomavirus prevalence in symptomatic preputium : a cross-sectional study of 351 circumcised men in Sweden
(
- Contribution to journal › Article
-
Mark
Quality of life with pharmacological treatment in patients with benign prostatic enlargement : results from the Evolution European Prospective Multicenter Multi-National Registry Study
(
- Contribution to journal › Article
-
Mark
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer : Analysis of Pain and Fatigue in the Phase 3 TITAN Study
(
- Contribution to journal › Article
-
Mark
Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer : 8-Year Follow-up
(
- Contribution to journal › Article
-
Mark
Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume
(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Immune Checkpoint Inhibitor–based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
(
- Contribution to journal › Debate/Note/Editorial